We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.61B
AUM Growth
+$5.44M
Cap. Flow
-$59.8M
Cap. Flow %
-3.72%
Top 10 Hldgs %
40.15%
Holding
64
New
1
Increased
1
Reduced
58
Closed
3

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$1.87M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.2M
2
MET icon
MetLife
MET
+$2.96M
3
CVS icon
CVS Health
CVS
+$2.91M
4
ALL icon
Allstate
ALL
+$2.57M
5
CSCO icon
Cisco
CSCO
+$2.46M

Sector Composition

Rank Sector Weight
1 Healthcare 24.25%
2 Financials 18.28%
3 Technology 10.27%
4 Consumer Staples 9.91%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MET icon
1
MetLife
MET
$62.5B
$85.9M 5.34%
1,434,851
-46,650
-3% -$2.96M
CVS icon
2
CVS Health
CVS
$134B
$78.5M 4.88%
941,339
-35,526
-4% -$2.91M
ALL icon
3
Allstate
ALL
$68.3B
$71.3M 4.43%
546,583
-19,875
-4% -$2.57M
XOM icon
4
ExxonMobil
XOM
$651B
$68.7M 4.27%
1,089,792
-35,950
-3% -$2.15M
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$68.2M 4.24%
1,296,355
-44,475
-3% -$2.39M
CSCO icon
6
Cisco
CSCO
$448B
$66.2M 4.11%
1,249,403
-46,825
-4% -$2.46M
CVX icon
7
Chevron
CVX
$383B
$64.2M 3.99%
612,472
-20,800
-3% -$2.2M
VZ icon
8
Verizon
VZ
$193B
$50.1M 3.11%
894,666
-42,790
-5% -$2.46M
GD icon
9
General Dynamics
GD
$103B
$48.8M 3.03%
259,449
-5,155
-2% -$972K
MRK icon
10
Merck
MRK
$321B
$44.3M 2.75%
569,530
-43,005
-7% -$3.2M
KO icon
11
Coca-Cola
KO
$381B
$44.3M 2.75%
817,882
-31,150
-4% -$1.69M
UNH icon
12
UnitedHealth
UNH
$383B
$41.2M 2.56%
102,850
-1,670
-2% -$666K
EXC icon
13
Exelon
EXC
$46.6B
$39.8M 2.47%
1,257,750
-49,911
-4% -$1.61M
T icon
14
AT&T
T
$159B
$39.4M 2.45%
1,813,611
-82,994
-4% -$1.89M
UNP icon
15
Union Pacific
UNP
$172B
$38.7M 2.41%
176,050
-7,400
-4% -$1.65M
IBM icon
16
IBM
IBM
$209B
$38.5M 2.39%
274,441
-10,335
-4% -$1.41M
MMM icon
17
3M
MMM
$90.8B
$37.6M 2.33%
226,247
-8,731
-4% -$1.46M
JNJ icon
18
Johnson & Johnson
JNJ
$617B
$37.2M 2.31%
225,825
-6,025
-3% -$997K
AMGN icon
19
Amgen
AMGN
$209B
$34.7M 2.15%
142,295
-6,875
-5% -$1.69M
ABBV icon
20
AbbVie
ABBV
$455B
$32M 1.99%
283,658
-6,775
-2% -$763K
GS icon
21
Goldman Sachs
GS
$302B
$31.3M 1.94%
82,428
-3,237
-4% -$1.16M
PFE icon
22
Pfizer
PFE
$142B
$30.9M 1.92%
788,540
-13,065
-2% -$508K
WMT icon
23
Walmart Inc
WMT
$884B
$30.2M 1.88%
642,120
-30,825
-5% -$1.44M
PG icon
24
Procter & Gamble
PG
$335B
$29.9M 1.86%
221,675
-10,440
-4% -$1.41M
ORCL icon
25
Oracle
ORCL
$367B
$26.2M 1.63%
336,565
-12,775
-4% -$1M
1
2 3

Similar funds

FCP
Fidelis Capital Partners Tampa, Florida $1.4B AUM 31.16% 1-Year Est. Return
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
IAS
Insigneo Advisory Services Miami, Florida $1.41B AUM 27.46% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
SP
Steelhead Partners Seattle, Washington $1.39B AUM 0.01% 1-Year Est. Return

Edgar Lomax Company's Q2 2021 Portfolio in Review

As of Q2 2021, Edgar Lomax Company held 64 positions worth $1.61B, up 0.34% from $1.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Edgar Lomax Company withdrew a net $59.8M in Q2 2021, closing 3 positions and reducing 58 holdings. Its most notable exit was Markel Group, an estimated $296K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Edgar Lomax Company opened a new position in Organon & Co worth $1.72M.

  • Edgar Lomax Company's largest Q2 2021 buy was Organon & Co: 56,949 shares worth $1.72M.
  • Edgar Lomax Company's biggest Q2 2021 reduction was Merck, cutting an estimated $3.2M.
  • Edgar Lomax Company fully exited Markel Group in Q2 2021, selling an estimated $296K.
  • Edgar Lomax Company's ten largest holdings make up 40% of its $1.61B portfolio in Q2 2021.
  • Edgar Lomax Company opened 1 new position and closed 3 in Q2 2021.
  • Edgar Lomax Company's portfolio value rose 0.34% quarter-over-quarter to $1.61B.

Based on Edgar Lomax Company's 13F filing for Q2 2021, filed 9 Aug 2021.